METHYLPHENIDATE ER 20 MG TAB

What it is

METHYLPHENIDATE ER 20 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “methylphenidate hydrochloride” and “methylphenidate hydrochloride extended release”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, extended release” and “tablet” and its route as oral.

Its labelers, the companies named on the label, are SpecGx LLC, KVK-Tech, Inc. and Granules Pharmaceuticals Inc.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $15.39 for 30 tablets (30 × $0.51315 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

All 3 NDCs

• 00406-1473-01 · SpecGx LLC · $0.51315 per EA · eff. 2026-09-23 filed
• 10702-0076-01 · KVK-Tech, Inc. · $0.51315 per EA · eff. 2026-09-23 filed
• 70010-0043-01 · Granules Pharmaceuticals Inc. · $0.51315 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

59 other products in the NADAC file share an FDA nonproprietary name with METHYLPHENIDATE ER 20 MG TAB. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-10-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $0.51315 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 164 have a higher middle NADAC price and 39 a lower one. The one in the middle is FOCALIN XR 5 MG CAPSULE, at $4.70352 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $68.41 for 30 tablets, at an average of $2.28047 per EA in 2024 (2024-01-01 to 2024-12-31) for “Methylphenidate ER” and “Methylphenidate HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 225,973 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.